The webinar will feature a presentation by Key Opinion Leader (KOL) Kimberly Cress, M.D. (Greenbrook TMS NeuroHealth Centers) who will discuss the current treatment landscape and unmet medical need in treating patients with obsessive-compulsive disorder (OCD) and how the BrainsWay Deep TMS™ therapy fits into the treatment paradigm. Dr. Cress will be available to answer questions following the formal presentations.

BrainsWay’s Chief Medical Officer, Dr. Aron Tendler, will also join to share some of the robust body of clinical evidence. Deep TMS is a noninvasive neurostimulation treatment that produces significant results by directly stimulating deeper and broader areas of the brain, effectively treating mental health disorders such as major depressive disorder, OCD, and smoking addiction.